{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T01:01:35Z","timestamp":1784682095489,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":98,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04390-6","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T12:14:30Z","timestamp":1776255270000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A sequential dual-drug delivery system for multi-target inhibition of subretinal fibrosis"],"prefix":"10.1186","volume":"24","author":[{"given":"Yu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cunzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxi","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"issue":"10386","key":"4390_CR1","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(22)02609-5","volume":"401","author":"RH Guymer","year":"2023","unstructured":"Guymer RH, Campbell TG. Age-related macular degeneration. Lancet. 2023;401(10386):1459\u201372.","journal-title":"Lancet"},{"issue":"12","key":"4390_CR2","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1038\/eye.2017.143","volume":"31","author":"A Lotery","year":"2017","unstructured":"Lotery A, Griner R, Ferreira A, Milnes F, Dugel P. Real-world visual acuity outcomes between ranibizumab and aflibercept in treatment of neovascular AMD in a large US data set. Eye (Lond). 2017;31(12):1697\u2013706.","journal-title":"Eye (Lond)"},{"issue":"3","key":"4390_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00441-021-03514-8","volume":"387","author":"L Tenbrock","year":"2022","unstructured":"Tenbrock L, Wolf J, Boneva S, Schlecht A, Agostini H, Wieghofer P, Schlunck G, Lange C. Subretinal fibrosis in neovascular age-related macular degeneration: current concepts, therapeutic avenues, and future perspectives. Cell Tissue Res. 2022;387(3):361\u201375.","journal-title":"Cell Tissue Res"},{"issue":"2","key":"4390_CR4","doi-asserted-by":"publisher","first-page":"378","DOI":"10.4103\/NRR.NRR-D-23-01642","volume":"20","author":"J Zhang","year":"2025","unstructured":"Zhang J, Sheng X, Ding Q, Wang Y, Zhao J, Zhang J. Subretinal fibrosis secondary to neovascular age-related macular degeneration: mechanisms and potential therapeutic targets. Neural Regen Res. 2025;20(2):378\u201393.","journal-title":"Neural Regen Res"},{"key":"4390_CR5","doi-asserted-by":"crossref","unstructured":"Heloter\u00e4 H, Kaarniranta K. A linkage between angiogenesis and inflammation in neovascular age-related macular degeneration. Cells. 2022;11(21):3453.","DOI":"10.3390\/cells11213453"},{"key":"4390_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.exer.2015.03.009","volume":"142","author":"K Ishikawa","year":"2016","unstructured":"Ishikawa K, Kannan R, Hinton DR. Molecular mechanisms of subretinal fibrosis in age-related macular degeneration. Exp Eye Res. 2016;142:19\u201325.","journal-title":"Exp Eye Res"},{"key":"4390_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106250","volume":"185","author":"D Liu","year":"2023","unstructured":"Liu D, Zhang C, Zhang J, Xu GT, Zhang J. Molecular pathogenesis of subretinal fibrosis in neovascular AMD focusing on epithelial-mesenchymal transformation of retinal pigment epithelium. Neurobiol Dis. 2023;185:106250.","journal-title":"Neurobiol Dis"},{"key":"4390_CR8","doi-asserted-by":"crossref","unstructured":"Shu DY, Butcher E, Saint-Geniez M. EMT and endMT: emerging roles in age-related macular degeneration. Int J Mol Sci. 2020;21(12):4271.","DOI":"10.3390\/ijms21124271"},{"issue":"4","key":"4390_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.arr.2009.06.002","volume":"8","author":"O Arjamaa","year":"2009","unstructured":"Arjamaa O, Nikinmaa M, Salminen A, Kaarniranta K. Regulatory role of HIF-1alpha in the pathogenesis of age-related macular degeneration (AMD). Ageing Res Rev. 2009;8(4):349\u201358.","journal-title":"Ageing Res Rev"},{"key":"4390_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100906","volume":"82","author":"PS Mettu","year":"2021","unstructured":"Mettu PS, Allingham MJ, Cousins SW. Incomplete response to anti-VEGF therapy in neovascular AMD: exploring disease mechanisms and therapeutic opportunities. Prog Retin Eye Res. 2021;82:100906.","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"4390_CR11","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/carcin\/bgy038","volume":"39","author":"L Rosenberg","year":"2018","unstructured":"Rosenberg L, Yoon CH, Sharma G, Bertagnolli MM, Cho NL. Sorafenib inhibits proliferation and invasion in desmoid-derived cells by targeting Ras\/MEK\/ERK and PI3K\/Akt\/mTOR pathways. Carcinogenesis. 2018;39(5):681\u20138.","journal-title":"Carcinogenesis"},{"key":"4390_CR12","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.ijbiomac.2022.09.129","volume":"221","author":"S Vimalraj","year":"2022","unstructured":"Vimalraj S. A concise review of VEGF, PDGF, FGF, Notch, angiopoietin, and HGF signalling in tumor angiogenesis with a focus on alternative approaches and future directions. Int J Biol Macromol. 2022;221:1428\u201338.","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"4390_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.154","volume":"4","author":"YL Chen","year":"2013","unstructured":"Chen YL, Zhang X, Bai J, Gai L, Ye XL, Zhang L, et al. Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation. Cell Death Dis. 2013;4(6):e665.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4390_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-0187-x","volume":"5","author":"W Tang","year":"2020","unstructured":"Tang W, Chen Z, Zhang W, Cheng Y, Zhang B, Wu F, et al. The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects. Signal Transduct Target Ther. 2020;5(1):87.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"4390_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23583","volume":"38","author":"M Li","year":"2024","unstructured":"Li M, Ying M, Gu S, Zhou Z, Zhao R. Matrine alleviates hypoxia-induced inflammation and pulmonary vascular remodelling via RPS5\/NF-kappaB signalling pathway. J Biochem Mol Toxicol. 2024;38(1):e23583.","journal-title":"J Biochem Mol Toxicol"},{"key":"4390_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01437","volume":"10","author":"X Hong","year":"2019","unstructured":"Hong X, Zhong L, Xie Y, Zheng K, Pang J, Li Y, et al. Matrine reverses the Warburg effect and suppresses colon cancer cell growth via negatively regulating HIF-1alpha. Front Pharmacol. 2019;10:1437.","journal-title":"Front Pharmacol"},{"issue":"1","key":"4390_CR17","doi-asserted-by":"publisher","first-page":"9520","DOI":"10.1038\/s41598-021-89086-7","volume":"11","author":"J Kang","year":"2021","unstructured":"Kang J, Liu S, Song Y, Chu Y, Wang M, Shi Y, Zhang F, Zhu L. Matrine treatment reduces retinal ganglion cell apoptosis in experimental optic neuritis. Sci Rep. 2021;11(1):9520.","journal-title":"Sci Rep"},{"issue":"4","key":"4390_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1548","volume":"11","author":"DA Srinivasarao","year":"2019","unstructured":"Srinivasarao DA, Lohiya G, Katti DS. Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019;11(4):e1548.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"4390_CR19","doi-asserted-by":"publisher","first-page":"132086","DOI":"10.1016\/j.ijbiomac.2024.132086","volume":"269Pt 1","author":"C Yu","year":"2024","unstructured":"Yu C, Xu J, Heidari G, Jiang H, Shi Y, Wu A, Makvandi P, Neisiany RE, Zare EN, Shao M, Hu L. Injectable hydrogels based on biopolymers for the treatment of ocular diseases. Int J Biol Macromol. 2024;269Pt 1:132086.","journal-title":"Int J Biol Macromol"},{"key":"4390_CR20","doi-asserted-by":"crossref","unstructured":"Hsu XL, Wu LC, Hsieh JY, Huang YY. Nanoparticle-hydrogel composite drug delivery system for potential ocular applications. Polymers (Basel). 2021;13(4):642.","DOI":"10.3390\/polym13040642"},{"key":"4390_CR21","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jconrel.2020.07.031","volume":"326","author":"BC Ilochonwu","year":"2020","unstructured":"Ilochonwu BC, Urtti A, Hennink WE, Vermonden T. Intravitreal hydrogels for sustained release of therapeutic proteins. J Control Release. 2020;326:419\u201341.","journal-title":"J Control Release"},{"key":"4390_CR22","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ajo.2022.09.008","volume":"246","author":"KX Cheong","year":"2023","unstructured":"Cheong KX, Cheung CMG, Teo KYC. Review of fibrosis in neovascular age-related macular degeneration. Am J Ophthalmol. 2023;246:192\u2013222.","journal-title":"Am J Ophthalmol"},{"key":"4390_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2019.104993","volume":"137","author":"S Awwad","year":"2019","unstructured":"Awwad S, Abubakre A, Angkawinitwong U, Khaw PT, Brocchini S. In situ antibody-loaded hydrogel for intravitreal delivery. Eur J Pharm Sci. 2019;137:104993.","journal-title":"Eur J Pharm Sci"},{"key":"4390_CR24","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jconrel.2017.10.031","volume":"268","author":"K Wang","year":"2017","unstructured":"Wang K, Han Z. Injectable hydrogels for ophthalmic applications. J Control Release. 2017;268:212\u201324.","journal-title":"J Control Release"},{"issue":"11","key":"4390_CR25","doi-asserted-by":"publisher","first-page":"5968","DOI":"10.1021\/acsbiomaterials.3c00672","volume":"9","author":"X Wang","year":"2023","unstructured":"Wang X, Li F, Liu X, Zhang H. Applications and recent developments of hydrogels in ophthalmology. ACS Biomater Sci Eng. 2023;9(11):5968\u201384.","journal-title":"ACS Biomater Sci Eng"},{"issue":"11","key":"4390_CR26","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.64.11.19","volume":"64","author":"K Cui","year":"2023","unstructured":"Cui K, Tang X, Hu A, Fan M, Wu P, Lu X, et al. Therapeutic benefit of melatonin in choroidal neovascularization during aging through the regulation of senescent macrophage\/microglia polarization. Invest Ophthalmol Vis Sci. 2023;64(11):19.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4390_CR27","doi-asserted-by":"crossref","unstructured":"Marchesi N, Capierri M, Pascale A, Barbieri A. Different therapeutic approaches for dry and wet AMD. Int J Mol Sci. 2024;25(23):13053.","DOI":"10.3390\/ijms252313053"},{"key":"4390_CR28","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","volume":"57","author":"EM Del Amo","year":"2017","unstructured":"Del Amo EM, Rimpela AK, Heikkinen E, Kari OK, Ramsay E, Lajunen T, Schmitt M, Pelkonen L, Bhattacharya M, Richardson D, Subrizi A, Turunen T, Reinisalo M, Itkonen J, Toropainen E, Casteleijn M, Kidron H, Antopolsky M, Vellonen KS, Ruponen M, Urtti A. Pharmacokinetic aspects of retinal drug delivery. Prog Retin Eye Res. 2017;57:134\u201385.","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"4390_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.exer.2011.11.007","volume":"94","author":"S Qin","year":"2012","unstructured":"Qin S, Rodrigues GA. Roles of alphavbeta5, FAK and MerTK in oxidative stress inhibition of RPE cell phagocytosis. Exp Eye Res. 2012;94(1):63\u201370.","journal-title":"Exp Eye Res"},{"key":"4390_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2021.100966","volume":"85","author":"I Van Hove","year":"2021","unstructured":"Van Hove I, Hu TT, Beets K, Van Bergen T, Etienne I, Stitt AW, et al. Targeting RGD-binding integrins as an integrative therapy for diabetic retinopathy and neovascular age-related macular degeneration. Prog Retin Eye Res. 2021;85:100966.","journal-title":"Prog Retin Eye Res"},{"issue":"32","key":"4390_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403399","volume":"11","author":"Y Wu","year":"2024","unstructured":"Wu Y, Li X, Fu X, Huang X, Zhang S, Zhao N, et al. Innovative nanotechnology in drug delivery systems for advanced treatment of posterior segment ocular diseases. Adv Sci Weinh. 2024;11(32):e2403399.","journal-title":"Adv Sci Weinh"},{"key":"4390_CR32","doi-asserted-by":"crossref","unstructured":"Tsai CH, Wang PY, Lin IC, Huang H, Liu GS, Tseng CL. Ocular drug delivery: role of degradable polymeric nanocarriers for ophthalmic application. Int J Mol Sci. 2018;19(9):2830.","DOI":"10.3390\/ijms19092830"},{"key":"4390_CR33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jare.2023.06.004","volume":"60","author":"YC Yang","year":"2024","unstructured":"Yang YC, Chien Y, Yarmishyn AA, Lim LY, Tsai HY, Kuo WC, Tsai PH, Yang SH, Hong SI, Chen SJ, Hwang DK, Yang YP, Chiou SH. Inhibition of oxidative stress-induced epithelial-mesenchymal transition in retinal pigment epithelial cells of age-related macular degeneration model by suppressing ERK activation. J Adv Res. 2024;60:141\u201357.","journal-title":"J Adv Res"},{"issue":"13","key":"4390_CR34","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202400540RRR","volume":"38","author":"C Shoda","year":"2024","unstructured":"Shoda C, Lee D, Miwa Y, Yamagami S, Nakashizuka H, Nimura K, et al. Inhibition of hypoxia-inducible factors suppresses subretinal fibrosis. FASEB J. 2024;38(13):e23792.","journal-title":"FASEB J"},{"issue":"6","key":"4390_CR35","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s13346-021-01043-z","volume":"12","author":"MF Adrianto","year":"2022","unstructured":"Adrianto MF, Annuryanti F, Wilson CG, Sheshala R, Thakur RRS. In vitro dissolution testing models of ocular implants for posterior segment drug delivery. Drug Deliv Transl Res. 2022;12(6):1355\u201375.","journal-title":"Drug Deliv Transl Res"},{"issue":"10","key":"4390_CR36","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1007\/s13346-024-01566-1","volume":"14","author":"K Naik","year":"2024","unstructured":"Naik K, du Toit LC, Ally N, Choonara YE. In vivo evaluation of a Nano-enabled therapeutic vitreous substitute for the precise delivery of triamcinolone to the posterior segment of the eye. Drug Deliv Transl Res. 2024;14(10):2668\u201394.","journal-title":"Drug Deliv Transl Res"},{"key":"4390_CR37","doi-asserted-by":"crossref","unstructured":"Rimpel\u00e4 AK, Kiiski I, Deng F, Kidron H, Urtti A. Pharmacokinetic simulations of intravitreal biologicals: aspects of drug delivery to the posterior and anterior segments. Pharmaceutics. 2018;11(1):9.","DOI":"10.3390\/pharmaceutics11010009"},{"issue":"11","key":"4390_CR38","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/nprot.2013.135","volume":"8","author":"V Lambert","year":"2013","unstructured":"Lambert V, Lecomte J, Hansen S, Blacher S, Gonzalez ML, Struman I, Sounni NE, Rozet E, de Tullio P, Foidart JM, Rakic JM, Noel A. Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice. Nat Protoc. 2013;8(11):2197\u2013211.","journal-title":"Nat Protoc"},{"key":"4390_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2023.109428","volume":"229","author":"S Zandi","year":"2023","unstructured":"Zandi S, Li Y, Jahnke L, Schweri-Olac A, Ishikawa K, Wada I, et al. Animal model of subretinal fibrosis without active choroidal neovascularization. Exp Eye Res. 2023;229:109428.","journal-title":"Exp Eye Res"},{"issue":"2","key":"4390_CR40","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/ceo.13367","volume":"47","author":"K Balaskas","year":"2019","unstructured":"Balaskas K, Ali ZC, Saddik T, Gemenetzi M, Patel P, Aslam TM. Swept-source optical coherence tomography angiography features of sub-retinal fibrosis in neovascular age-related macular degeneration. Clin Exp Ophthalmol. 2019;47(2):233\u20139.","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"4390_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-02033-7","volume":"17","author":"K Little","year":"2020","unstructured":"Little K, Llorian-Salvador M, Tang M, Du X, Marry S, Chen M, et al. Macrophage to myofibroblast transition contributes to subretinal fibrosis secondary to neovascular age-related macular degeneration. J Neuroinflammation. 2020;17(1):355.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"4390_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02433-x","volume":"19","author":"C Yi","year":"2022","unstructured":"Yi C, Liu J, Deng W, Luo C, Qi J, Chen M, et al. Macrophage elastase (MMP12) critically contributes to the development of subretinal fibrosis. J Neuroinflammation. 2022;19(1):78.","journal-title":"J Neuroinflammation"},{"key":"4390_CR43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ejpb.2015.05.016","volume":"95Pt B","author":"S Kirchhof","year":"2015","unstructured":"Kirchhof S, Goepferich AM, Brandl FP. Hydrogels in ophthalmic applications. Eur J Pharm Biopharm. 2015;95Pt B:227\u201338.","journal-title":"Eur J Pharm Biopharm"},{"key":"4390_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.coco.2025.102533","volume":"58","author":"J Liang","year":"2025","unstructured":"Liang J, Said FM, Xu X, Guo S, Li Y, Jing Z. Biodegradable and biocompatible agarose-based double-network composite hydrogels embedded with hydroxyapatite@Angelica dahurica polysaccharide composite for wound hemostasis. Compos Commun. 2025;58:102533.","journal-title":"Compos Commun"},{"issue":"12","key":"4390_CR45","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1080\/10601325.2021.1964368","volume":"58","author":"W-J Zhang","year":"2021","unstructured":"Zhang W-J, Yan Y-Z, Nagappan S, He S, Ha C-S, Jin Y-S. Dual (thermo-\/pH-) responsive P(NIPAM-co-AA-co-HEMA) nanocapsules for controlled release of 5-fluorouracil. J Macromol Sci A. 2021;58(12):860\u201371.","journal-title":"J Macromol Sci A"},{"issue":"17","key":"4390_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202008553","volume":"33","author":"BR Freedman","year":"2021","unstructured":"Freedman BR, Uzun O, Luna NMM, Rock A, Clifford C, Stoler E, et al. Degradable and removable tough adhesive hydrogels. Adv Mater. 2021;33(17):e2008553.","journal-title":"Adv Mater"},{"key":"4390_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodhyd.2020.105702","volume":"104","author":"L Zhou","year":"2020","unstructured":"Zhou L, Xu T, Yan J, Li X, Xie Y, Chen H. Fabrication and characterization of matrine-loaded konjac glucomannan\/fish gelatin composite hydrogel as antimicrobial wound dressing. Food Hydrocolloids. 2020;104:105702.","journal-title":"Food Hydrocolloids"},{"issue":"1","key":"4390_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-01829-y","volume":"21","author":"W Su","year":"2023","unstructured":"Su W, Liu C, Jiang X, Lv Y, Chen Q, Shi J, et al. An intravitreal-injectable hydrogel depot doped borneol-decorated dual-drug-coloaded microemulsions for long-lasting retina delivery and synergistic therapy of wAMD. J Nanobiotechnology. 2023;21(1):71.","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"4390_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-025-00648-5","volume":"20","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Zhang Y, Li J, Zhang Y, Qu Y. The role of IGF2BP2 in macrophage-mediated NLRP3 inflammasome activation in the pathogenesis of dry AMD. Biol Direct. 2025;20(1):57.","journal-title":"Biol Direct"},{"key":"4390_CR50","doi-asserted-by":"crossref","unstructured":"Li J, Tian Q, Sun H, Zhang Y, Yang X, Kaur P, et al. A novel, liposome-loaded, injectable hydrogel for enhanced treatment of choroidal neovascularization by sub-tenon's injection. Mater Today Nano. 2022;20:100264.","DOI":"10.1016\/j.mtnano.2022.100264"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04390-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04390-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04390-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:04:09Z","timestamp":1784678649000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04390-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4390"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04390-6","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Further details are available in the Supporting Information hosted by the Wiley Online Library or available from the author on request.","order":2,"name":"Ethics","label":"Supporting Information","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"686"}}